Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Houston, Texas 77030


Purpose:

The purpose of this study is to evaluate the best timing for administering pneumococcal vaccine (PV) to HIV-infected adults that have CD4 cell counts of more than 200 and are not yet receiving combination antiretroviral treatment (ART). Participants in this study will be assigned by chance to receive vaccination with PV prior to starting ART or after at least 6 months of ART. Antibody levels to components of the PV will be measured at 6 months and 12 months after vaccination. The results will tell us if patients that receive PV after 6 months of ART have better response to the vaccine than those that get vaccinated prior to treatment.


Criteria:

Inclusion Criteria: - HIV infected - CD4 count >200 - no acute illness - no pneumococcal vaccination within 3 years - naive to treatment or if previously on treatment, no antiretroviral treatment for at least 6 months - willingness to start antiretroviral treatment as recommended by current guidelines Exclusion Criteria: - prior pneumococcal vaccination within 3 years - prior AIDS diagnosis based on opportunistic disease - acute illness


NCT ID:

NCT00706550


Primary Contact:

Principal Investigator
Maria Rodriguez-Barradas, MD
Michael E DeBakey VA Medical Center


Backup Contact:

N/A


Location Contact:

Houston, Texas 77030
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 23, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.